OBJECTIVE： To observe the effects of Shenqi fuzheng injection combined with Nimodipine tablet on blood indicators of cerebral infarction patients in the recovery period. METHODS： 58 patients diagnosed as cerebral infarction in the recovery period were collected and randomly divided into control group and trial group， with 29 cases in each group. Control group  was given Nimodipine tablet 30 mg， tid； trial group was additionally given Shenqi fuzheng injection 250 ml， qd， ivgtt. Both group received 14 d of treatment. After treatment， the levels of serum hs-CRP， Fractalkine， tPA， PAI-1， blood rheology index and plasma fibrinogen （FIB） were observed in 2 groups. RESULTS： After treatment， the levels of serum hs-CRP， Fractalkine， blood rheology index PAI-1 and FIB decreased in trial group， while tPA activity increased； there was statistical significance between trial group and control group （P＜0.05）. CONCLUSIONS： Shenqi fuzheng injection combined with Nimodipine tablet can significantly improve the serum hs-CRP and Fractalkine levels， blood rheology indicators， PAI-1 and FIB， and improve tPA activity.